We are improving the technology to help end the diagnostic odyssey of rare disease patients.

Undiagnosed patients can meet 3billion and make an end to their diagnostic odyssey

3billion was founded aiming to end diagnostic odyssey of rare disease patients by comprehensive genetic testing. By using bioinformatics and machine learning technology, we have reduced significant amount of time and cost that used to be required for genome interpretation, making the genome-scale rare disease genetic testing affordable for patients in need.